016580 fundamentals
WHANIN PHARM revenue breakdown overview
WHANIN PHARM revenue for the last year amounted to 259.60 B KRW, the most of which — 259.60 B KRW — came from its highest performing source at the moment, Pharmaceutical. The greatest contribution to the revenue figure was made by South Korea — last year it brought WHANIN PHARM 259.60 B KRW, and the year before that — 230.39 B KRW.
By source
By country